An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for EMERGENT BIOSOLUTIONS Inc
| Ticker | EBS |
| FIGI | BBG000GW06J7 |
| CUSIP | 29089Q105 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 134 / 1.9% |
| Percentage held by institutional investors | 63.1% |
About
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Among the company's products are the controversial BioThrax (Anthrax Vaccine Adsorbed), the only anthrax vaccine licensed by the U.S. Food and Drug Administration (FDA) and Narcan (naloxone) for the emergency treatment of opioid overdose. Wikipedia